DOCK8 drives Src-dependent NK Cell effector function

Journal of Immunology

Volumn 199, Issue 6, 2017, Pages 2118-2127

  Kearney, Conor J ^a,b   Vervoort, Stephin J ^a   Ramsbottom, Kelly M ^a   Freeman, Andrew J ^a   Michie, Jessica ^a   Peake, Jane ^c   Casanova, Jean Laurent ^d,e,f,g   Picard, Capucine ^d,e   Tangye, Stuart G ^h,i   Ma, Cindy S ^h,i   Johnstone, Ricky W ^a   Randall, Katrina L ^j,k   Oliaro, Jane ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d IMAGINE INSTITUTE   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f ROCKEFELLER UNIVERSITY   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j Australian National University   (Australia)

^k Canberra Hospital   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 8; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DOCK8 GENE; ENZYME ACTIVATION; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 85028985289     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1700751     Document Type: Article

References (38)

1. Su, H. C. 2010. Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr. Opin. Allergy Clin. Immunol. 10: 515-520.
2. Zhang, Q., J. C. Davis, I. T. Lamborn, A. F. Freeman, H. Jing, A. J. Favreau, H. F. Matthews, J. Davis, M. L. Turner, G. Uzel, et al. 2009. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361: 2046- 2055.
3. Su, H. C. 2010. Combined immunodeficiency associated with DOCK8 mutations and related immunodeficiencies. Dis. Markers 29: 121-122
4. Laurin, M., and J. F. Côté. 2014. Insights into the biological functions of dock family guanine nucleotide exchange factors. Genes Dev. 28: 533-547.
5. Randall, K. L., T. Lambe, A. L. Johnson, B. Treanor, E. Kucharska, H. Domaschenz, B. Whittle, L. E. Tze, A. Enders, T. L. Crockford, et al. 2009. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. [Published erratum appears in 2010 Nat. Immunol. 11: 644.] Nat. Immunol. 10: 1283-1291.
6. Randall, K. L., S. S. Chan, C. S. Ma, I. Fung, Y. Mei, M. Yabas, A. Tan, P. D. Arkwright, W. Al Suwairi, S. O. Lugo Reyes, et al. 2011. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J. Exp. Med. 208: 2305-2320.
7. Crawford, G., A. Enders, U. Gileadi, S. Stankovic, Q. Zhang, T. Lambe, T. L. Crockford, H. E. Lockstone, A. Freeman, P. D. Arkwright, et al. 2013. DOCK8 is critical for the survival and function of NKT cells. Blood 122: 2052- 2061.
8. Zhang, Q., C. G. Dove, J. L. Hor, H. M. Murdock, D. M. Strauss-Albee, J. A. Garcia, J. N. Mandl, R. A. Grodick, H. Jing, D. B. Chandler-Brown, et al. 2014. DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. J. Exp. Med. 211: 2549-2566.
9. Flesch, I. E., K. L. Randall, N. A. Hollett, H. Di Law, L. A. Miosge, Y. Sontani, C. C. Goodnow, and D. C. Tscharke. 2015. Delayed control of herpes simplex virus infection and impaired CD4(+) T-cell migration to the skin in mouse models of DOCK8 deficiency. Immunol. Cell Biol. 93: 517-521.
10. de la Roche, M., Y. Asano, and G. M. Griffiths. 2016. Origins of the cytolytic synapse. Nat. Rev. Immunol. 16: 421-432.
11. Dustin, M. L. 2014. The immunological synapse. Cancer Immunol. Res. 2: 1023-1033.
12. Kearney, C. J., A. J. Brennan, P. K. Darcy, and J. Oliaro. 2015. The role of the immunological synapse formed by cytotoxic lymphocytes in immunodeficiency and anti-tumor immunity. Crit. Rev. Immunol. 35: 325-347.
13. Orange, J. S. 2007. The lytic NK cell immunological synapse and sequential steps in its formation. Adv. Exp. Med. Biol. 601: 225-233.
14. Ham, H., S. Guerrier, J. Kim, R. A. Schoon, E. L. Anderson, M. J. Hamann, Z. Lou, and D. D. Billadeau. 2013. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J. Immunol. 190: 3661-3669.
15. Mizesko, M. C., P. P. Banerjee, L. Monaco-Shawver, E. M. Mace, W. E. Bernal, J. Sawalle-Belohradsky, B. H. Belohradsky, V. Heinz, A. F. Freeman, K. E. Sullivan, et al. 2013. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J. Allergy Clin. Immunol. 131: 840-848.
16. Janssen, E., M. Tohme, M. Hedayat, M. Leick, S. Kumari, N. Ramesh, M. J. Massaad, S. Ullas, V. Azcutia, C. C. Goodnow, et al. 2016. A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton. J. Clin. Invest. 126: 3837-3851.
17. Jabara, H. H., D. R. McDonald, E. Janssen, M. J. Massaad, N. Ramesh, A. Borzutzky, I. Rauter, H. Benson, L. Schneider, S. Baxi, et al. 2012. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat. Immunol. 13: 612-620.
18. Keles, S., L. M. Charbonnier, V. Kabaleeswaran, I. Reisli, F. Genel, N. Gulez, W. Al-Herz, N. Ramesh, A. Perez-Atayde, N. E. Karaca, et al. 2016. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation. J. Allergy Clin. Immunol. 138: 1384-1394.e2.
19. Tangye, S. G., B. Pillay, K. L. Randall, D. T. Avery, T. G. Phan, P. Gray, J. B. Ziegler, J. M. Smart, J. Peake, P. D. Arkwright, et al. 2017. DOCK8-deficient CD4+ T cells are biased to a Th2 effector fate at the expense of Th1 and Th17 cells. J. Allergy Clin. Immunol. 139: 933-949.
20. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
21. Oykhman, P., M. Timm-McCann, R. F. Xiang, A. Islam, S. S. Li, D. Stack, S. M. Huston, L. L. Ma, and C. H. Mody. 2013. Requirement and redundancy of the Src family kinases Fyn and Lyn in perforin-dependent killing of Cryptococcus neoformans by NK cells. Infect. Immun. 81: 3912-3922.
22. Chini, C. C., M. D. Boos, C. J. Dick, R. A. Schoon, and P. J. Leibson. 2000. Regulation of p38 mitogen-activated protein kinase during NK cell activation. Eur. J. Immunol. 30: 2791-2798.
23. Vivier, E., J. A. Nunès, and F. Vély. 2004. Natural killer cell signaling pathways. Science 306: 1517-1519.
24. House, I. G., K. Thia, A. J. Brennan, R. Tothill, A. Dobrovic, W. Z. Yeh, R. Saffery, Z. Chatterton, J. A. Trapani, and I. Voskoboinik. 2015. Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals. Immunol. Cell Biol. 93: 575-580.
25. Liao, Y., G. K. Smyth, and W. Shi. 2014. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30: 923-930.
26. Law, C. W., Y. Chen, W. Shi, and G. K. Smyth. 2014. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15: R29.
27. Liberzon, A., C. Birger, H. Thorvaldsdóttir, M. Ghandi, J. P. Mesirov, and P. Tamayo. 2015. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1: 417-425.
28. Brandt, C. S., M. Baratin, E. C. Yi, J. Kennedy, Z. Gao, B. Fox, B. Haldeman, C. D. Ostrander, T. Kaifu, C. Chabannon, et al. 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206: 1495-1503.
29. Mentlik, A. N., K. B. Sanborn, E. L. Holzbaur, and J. S. Orange. 2010. Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment. Mol. Biol. Cell 21: 2241-2256.
30. Kearney, C. J., K. L. Randall, and J. Oliaro. 2017. DOCK8 regulates signal transduction events to control immunity. Cell. Mol. Immunol. 14: 406-411.
31. Sedger, L. M., and M. F. McDermott. 2014. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 25: 453-472.
32. Trevejo, J. M., M. W. Marino, N. Philpott, R. Josien, E. C. Richards, K. B. Elkon, and E. Falck-Pedersen. 2001. TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc. Natl. Acad. Sci. USA 98: 12162-12167.
33. Murdaca, G., F. Spanò, M. Contatore, A. Guastalla, E. Penza, O. Magnani, and F. Puppo. 2015. Infection risk associated with anti-TNF-a agents: A review. Expert Opin. Drug Saf. 14: 571-582.
34. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-gamma: An overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189.
35. Zaretsky, J. M., A. Garcia-Diaz, D. S. Shin, H. Escuin-Ordinas, W. Hugo, S. Hu-Lieskovan, D. Y. Torrejon, G. Abril-Rodriguez, S. Sandoval, L. Barthly, et al. 2016. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375: 819-829.
36. Gao, J., L. Z. Shi, H. Zhao, J. Chen, L. Xiong, Q. He, T. Chen, J. Roszik, C. Bernatchez, S. E. Woodman, et al. 2016. Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy. Cell 167: 397-404.e399.
37. Yamamura, K., T. Uruno, A. Shiraishi, Y. Tanaka, M. Ushijima, T. Nakahara, M. Watanabe, M. Kido-Nakahara, I. Tsuge, M. Furue, and Y. Fukui. 2017. The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction. Nat. Commun. 8: 13946.
38. Kearney, C. J., C. Sheridan, S. P. Cullen, G. A. Tynan, S. E. Logue, I. S. Afonina, D. Vucic, E. C. Lavelle, and S. J. Martin. 2013. Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production. J. Biol. Chem. 288: 4878-4890.